Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Greene T, Ying J, Vonesh EF, Tighiouart H, Levey AS, Coresh J, Herrick JS, Imai E, Jafar TH, Maes BD, Perrone RD, Del Vecchio L, Wetzels JFM, Heerspink HJL, Inker LA.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010009. doi: 10.1681/ASN.2019010009. [Epub ahead of print]

PMID:
31292198
2.

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, Simon AL, Ying J, Beck GJ, Wanner C, Floege J, Li PK, Perkovic V, Vonesh EF, Greene T.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010007. doi: 10.1681/ASN.2019010007. [Epub ahead of print]

PMID:
31292197
3.

Calculating Standard Kt/V during Hemodialysis Based on Urea Mass Removed.

Leypoldt JK, Vonesh EF.

Blood Purif. 2019;47(1-3):62-68. doi: 10.1159/000493178. Epub 2018 Oct 8.

PMID:
30296780
4.

The authors reply.

Kumar VA, Sidell MA, Jones JP, Vonesh EF.

Kidney Int. 2015 Jun;87(6):1260. doi: 10.1038/ki.2015.55. No abstract available.

PMID:
26024034
5.

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system.

Kumar VA, Sidell MA, Jones JP, Vonesh EF.

Kidney Int. 2014 Nov;86(5):1016-22. doi: 10.1038/ki.2014.224. Epub 2014 Jul 2.

6.

PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness.

Ahrens MJ, Bertin PA, Vonesh EF, Meade TJ, Catalona WJ, Georganopoulou D.

Prostate. 2013 Dec;73(16):1731-7. doi: 10.1002/pros.22714. Epub 2013 Aug 9.

PMID:
23934862
7.

What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, Catalona WJ.

J Clin Oncol. 2011 Feb 1;29(4):464-7. doi: 10.1200/JCO.2010.30.6373. Epub 2010 Dec 28.

8.

Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applications.

Sloand JA, Leypoldt JK, Culleton BF, Gellens ME, Paniagua R, Amato D, Vonesh EF.

Clin J Am Soc Nephrol. 2011 Mar;6(3):598-604. doi: 10.2215/CJN.04970610. Epub 2010 Dec 16.

9.

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.

Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, Maccracken E, Mittal BB, Vokes EE, Haraf DJ.

Head Neck. 2007 Jul;29(7):632-7.

PMID:
17230558
10.

Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?

Vonesh EF, Snyder JJ, Foley RN, Collins AJ.

Kidney Int Suppl. 2006 Nov;(103):S3-11. Review.

11.

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Bárány P, Heimbürger O, Vonesh EF, Lindholm B.

Nephrol Dial Transplant. 2007 Jan;22(1):209-17. Epub 2006 Sep 17.

PMID:
16982634
12.

Modeling of icodextrin in PD Adequest 2.0.

Vonesh EF, Story KO, Douma CE, Krediet RT.

Perit Dial Int. 2006 Jul-Aug;26(4):475-81.

PMID:
16881343
13.

Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins.

Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):39-44.

14.

Shared parameter models for the joint analysis of longitudinal data and event times.

Vonesh EF, Greene T, Schluchter MD.

Stat Med. 2006 Jan 15;25(1):143-63.

PMID:
16025541
15.

The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.

Vonesh EF, Snyder JJ, Foley RN, Collins AJ.

Kidney Int. 2004 Dec;66(6):2389-401.

16.

Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States.

Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ.

J Am Soc Nephrol. 2004 Jan;15(1):174-9.

17.

Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout.

Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, Newman LA, May AH, MacCracken E, Gaziano J, Stachowiak L.

Head Neck. 2003 Dec;25(12):1034-41.

PMID:
14648862
18.

Body size and outcomes on peritoneal dialysis in the United States.

Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ.

Kidney Int. 2003 Nov;64(5):1838-44.

19.

The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis.

Kim GC, Vonesh EF, Korbet SM.

Perit Dial Int. 2002 Jan-Feb;22(1):53-9.

PMID:
11929145
20.

Validation of PD Adequest 2.0 for pediatric dialysis patients.

Warady BA, Watkins SL, Fivush BA, Andreoli SP, Salusky I, Kohaut EC, Vonesh EF.

Pediatr Nephrol. 2001 Mar;16(3):205-11.

PMID:
11322365
21.

Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting.

Tanna MM, Vonesh EF, Korbet SM.

Am J Kidney Dis. 2000 Dec;36(6):1175-82.

PMID:
11096042
22.
23.

A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.

Vonesh EF, Story KO, O'Neill WT.

Perit Dial Int. 1999 Nov-Dec;19(6):556-71.

PMID:
10641777
24.

Membrane transport models and computerized kinetic modeling applied to automated peritoneal dialysis.

Vonesh EF.

Contrib Nephrol. 1999;129:15-34. Review. No abstract available.

PMID:
10590860
25.

Racial differences in survival in an urban peritoneal dialysis program.

Korbet SM, Shih D, Cline KN, Vonesh EF.

Am J Kidney Dis. 1999 Oct;34(4):713-20.

PMID:
10516354
27.

Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model.

Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF.

J Am Soc Nephrol. 1999 Mar;10(3):601-9.

29.

Applications in kinetic modeling using PD ADEQUEST.

Vonesh EF, Keshaviah PR.

Perit Dial Int. 1997;17 Suppl 2:S119-25. No abstract available.

PMID:
9163811
30.

Discrepancies between urea KT/V versus normalized creatinine clearance.

Vonesh EF, Moran J.

Perit Dial Int. 1997 Jan-Feb;17(1):13-6. No abstract available.

PMID:
9068016
31.

Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.

Vonesh EF, Burkart J, McMurray SD, Williams PF.

Perit Dial Int. 1996 Sep-Oct;16(5):471-81.

PMID:
8914177
32.

Goodness-of-fit in generalized nonlinear mixed-effects models.

Vonesh EF, Chinchilli VM, Pu K.

Biometrics. 1996 Jun;52(2):572-87.

PMID:
10766504
33.

Peritonitis in an urban peritoneal dialysis program: an analysis of infecting pathogens.

Korbet SM, Vonesh EF, Firanek CA.

Am J Kidney Dis. 1995 Jul;26(1):47-53.

PMID:
7611267
34.

The PSA index does not correct for ultrafiltration.

Emerson PF, Vonesh EF.

Perit Dial Int. 1995;15(2):185-7. No abstract available.

PMID:
7612749
35.

Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis.

Keshaviah P, Emerson PF, Vonesh EF, Brandes JC.

J Am Soc Nephrol. 1994 Apr;4(10):1820-6.

36.

Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring.

Rodby RA, Vonesh EF, Korbet SM.

Am J Kidney Dis. 1994 Mar;23(3):401-11.

PMID:
8128942
37.

A retrospective assessment of risk factors for peritonitis among an urban CAPD population.

Korbet SM, Vonesh EF, Firanek CA.

Perit Dial Int. 1993;13(2):126-31.

PMID:
8494934
38.

A multicenter, selection-adjusted comparison of patient and technique survival on CAPD and hemodialysis: a clarification.

Vonesh EF, Maiorca R.

Perit Dial Int. 1993;13(1):71-2. No abstract available.

PMID:
8443287
39.

Relative risks can be risky.

Vonesh EF.

Perit Dial Int. 1993;13(1):5-9. No abstract available.

PMID:
8443277
40.

Non-linear models for the analysis of longitudinal data.

Vonesh EF.

Stat Med. 1992 Oct-Nov;11(14-15):1929-54.

PMID:
1480882
41.

Mixed-effects nonlinear regression for unbalanced repeated measures.

Vonesh EF, Carter RL.

Biometrics. 1992 Mar;48(1):1-17.

PMID:
1581479
42.

A random coefficient growth curve analysis of mental development in low-birth-weight infants.

Carter RL, Resnick MB, Ariet M, Shieh G, Vonesh EF.

Stat Med. 1992 Jan 30;11(2):243-56.

PMID:
1579762
43.

Net fluid absorption under membrane transport models of peritoneal dialysis.

Vonesh EF, Rippe B.

Blood Purif. 1992;10(3-4):209-26.

PMID:
1308685
44.

The effect of hematocrit on peritoneal transport.

Korbet SM, Vonesh EF, Firanek CA.

Am J Kidney Dis. 1991 Nov;18(5):573-8.

PMID:
1951337
45.

The influence of dialysis treatment modality on the decline of remaining renal function.

Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC.

ASAIO Trans. 1991 Oct-Dec;37(4):598-604.

PMID:
1768496
46.

Patient and technique survival among an urban population of peritoneal dialysis patients: an 8-year experience.

Firanek CA, Vonesh EF, Korbet SM.

Am J Kidney Dis. 1991 Jul;18(1):91-6. Erratum in: Am J Kidney Dis 1992 Jan;19(1):93.

PMID:
2063861
47.

Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study.

Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, et al.

Am J Kidney Dis. 1991 Apr;17(4):462-71.

PMID:
1901197
48.

A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis.

Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, Scarpioni LL, Bragantini L, Cancarini GC, Cantaluppi A, et al.

Perit Dial Int. 1991;11(2):118-27.

PMID:
1854867
49.

Kinetic modeling as a prescription aid in peritoneal dialysis.

Vonesh EF, Lysaght MJ, Moran J, Farrell P.

Blood Purif. 1991;9(5-6):246-70.

PMID:
1819315
50.

Which statistical method to use when analyzing the incidence of peritoneal dialysis related infections?

Vonesh EF.

Perit Dial Int. 1991;11(4):301-4. No abstract available.

PMID:
1751595

Supplemental Content

Loading ...
Support Center